Cardioprotective role of phoenixin-14 in isoproterenol-induced myocardial injury: Involvement of AMPK, JAK2/STAT3, and Sema3E pathways
| dc.contributor.author | Akcilar, Raziye | |
| dc.contributor.author | Tasar, Muhammed | |
| dc.contributor.author | Kar, Fatih | |
| dc.contributor.author | Ari, Neziha Senem | |
| dc.contributor.author | Saygili, Suna Karadeniz | |
| dc.contributor.author | Kocak, Fatma Emel | |
| dc.contributor.author | Kocak, Cengiz | |
| dc.date.accessioned | 2025-11-16T19:33:49Z | |
| dc.date.issued | 2025 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description.abstract | Aims: This study aimed to evaluate the cardioprotective effects of phoenixin-14 (PNX-14) in isoproterenol (ISO)-induced myocardial infarction (MI) in rats, comparing both preventive and therapeutic administration. Materials and methods: Seventy adult male Wistar rats were divided into five groups: Control, PNX-14, ISO, ISO + PNX-14 (PNX-14 treatment after ISO), and PNX-14 + ISO (PNX-14 pretreatment before ISO). MI was induced by subcutaneous ISO (100 mg/kg/day) for two days. PNX-14 (5 nmol/kg, intraperitoneally) was administered once daily for 3 days. Biochemical, molecular, and histopathological analyses were performed to evaluate oxidative stress, inflammatory response, and apoptosis in cardiac tissue. Key findings: PNX-14 treatment significantly reduced the ISO-induced increases in heart/body weight ratio (0.54 +/- 0.05), infarct size (47.3 +/- 2.51 %), apoptotic index (40.8 +/- 2.99 %), and cardiac necrosis markers CK-MB and TnI (p < 0.001). It improved antioxidant defenses by increasing glutathione (GSH) and total antioxidant status (TAS), while reducing total oxidant status (TOS) and oxidative stress index (OSI). Pro-inflammatory cytokines TNF-alpha and IL-6 were lowered, and anti-inflammatory IL-10 increased. PNX-14 also attenuated apoptosis in cardiac tissue by downregulating cytochrome c, APAF-1, caspase-3, and Bax, and upregulating the anti-apoptotic marker Bcl-2. These effects were linked to modulation of Gpr173, AMPK/Nrf2/HO-1, and Sema3E/PlexinD1 pathways, alongside suppression of JAK2/STAT3 and NF-kappa B signaling. Furthermore, PNX-14 improved hemodynamic stability and histopathologically reduced ISO-induced myocardial damage. Significance: These results demonstrate that PNX-14, particularly when administered after injury, effectively attenuates myocardial damage through multi-pathway regulation of oxidative stress, inflammation, and apoptosis. PNX-14 may hold therapeutic potential for the prevention and treatment of cardiovascular diseases. | |
| dc.description.sponsorship | Turkish Health Institutes Presidency [28557, 2022-A3-DR/TUS-03 A] | |
| dc.description.sponsorship | This project was supported by the Turkish Health Institutes Presidency under project number 28557, within the scope of the 2022-A3-DR/TUS-03 A Group Projects Support Program. | |
| dc.identifier.doi | 10.1016/j.lfs.2025.123896 | |
| dc.identifier.issn | 0024-3205 | |
| dc.identifier.issn | 1879-0631 | |
| dc.identifier.pmid | 40816502 | |
| dc.identifier.scopus | 2-s2.0-105013114174 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.uri | https://doi.org/10.1016/j.lfs.2025.123896 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/15145 | |
| dc.identifier.volume | 379 | |
| dc.identifier.wos | WOS:001554317800003 | |
| dc.identifier.wosquality | N/A | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Pergamon-Elsevier Science Ltd | |
| dc.relation.ispartof | Life Sciences | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.subject | Phoenixin 14 | |
| dc.subject | Myocardial infarction | |
| dc.subject | Oxidative stress | |
| dc.subject | Inflammation | |
| dc.subject | Apoptosis | |
| dc.title | Cardioprotective role of phoenixin-14 in isoproterenol-induced myocardial injury: Involvement of AMPK, JAK2/STAT3, and Sema3E pathways | |
| dc.type | Article |










